Home » Topics » Regulatory

Regulatory
RSS

Philippines is the first market for lamivudine as anti-HBV agent

Dec. 14, 1998

Schering-Plough files NDA for next-generation corticosteroid

Dec. 14, 1998

FDA approves Rebetron combination therapy for previously untreated HCV patients

Dec. 11, 1998

FDA approves Sandostatin LAR once-monthly depot formulation

Dec. 7, 1998

Canadian approval obtained for Serostim

Dec. 4, 1998

FDA approves Hycamtin as second-line treatment of small cell lung cancer

Dec. 4, 1998

FDA approves Verelan PM; launch scheduled for early 1999

Dec. 4, 1998

Genzyme General receives FDA approval for Thyrogen

Dec. 3, 1998

U.K. approval for new controlled-release nifedipine based on TIMERx technology

Dec. 2, 1998

FDA approves new indications, dosing regimens for Vantin

Dec. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...